Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma
about
Control of pre-mRNA splicing by the general splicing factors PUF60 and U2AF(65)A novel SR-related protein is required for the second step of Pre-mRNA splicingMolecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: immunological relationship with hnRNP PPUF60: a novel U2AF65-related splicing activityU2AF homology motifs: protein recognition in the RRM worldA novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinomaIsolation of suppressor genes that restore retrovirus susceptibility to a virus-resistant cell lineCancer-relevant Splicing Factor CAPERα Engages the Essential Splicing Factor SF3b155 in a Specific Ternary ComplexMolecular cloning and characterization of CAPER, a novel coactivator of activating protein-1 and estrogen receptorsSerologic responses in patients with malignant mesothelioma: evidence for both public and private specificities.De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma.Selective degradation of splicing factor CAPERα by anticancer sulfonamides.Identification of tumor-associated antigens as diagnostic and predictive biomarkers in cancer.Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokersPreferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigensCAPER, a novel regulator of human breast cancer progression.Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex.Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.Overexpression of HCC1/CAPERα may play a role in lung cancer carcinogenesis.Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies.Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.Conserved RNA-binding proteins required for dendrite morphogenesis in Caenorhabditis elegans sensory neurons.Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.Mechanisms for U2AF to define 3' splice sites and regulate alternative splicing in the human genomeA U1-U2 snRNP interaction network during intron definitionAutoantibodies against tumor-associated antigens for detection of hepatocellular carcinomaAutoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.ERRβ splice variants differentially regulate cell cycle progression.Nuclear receptor coactivator/coregulator NCoA6(NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development.Tumor-associated antigen arrays for the serological diagnosis of cancer.Triplex DNA-binding proteins are associated with clinical outcomes revealed by proteomic measurements in patients with colorectal cancer.Spatial mapping of splicing factor complexes involved in exon and intron definition.Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma.UHM-ULM interactions in the RBM39-U2AF65 splicing-factor complex.CAPERalpha is a novel Rel-TAD-interacting factor that inhibits lymphocyte transformation by the potent Rel/NF-kappaB oncoprotein v-Rel.Tumor-associated antigen CAPERα and microvessel density in hepatocellular carcinoma.Autoantibodies to tumor-associated antigens: reporters from the immune system.Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis.
P2860
Q21144446-0431A164-0C00-4EA9-90F6-38641A873870Q24299148-A9FE1C4F-8330-43F3-8613-87DCE176CD20Q24318358-EDE7F196-5AD0-4CC1-8841-961F0D066B4AQ24539523-631C6E1B-3AAF-453B-A49B-9D7783428F17Q24673218-C8A701EB-2934-4E2B-89B1-32DBB8C5C58DQ24676730-FE849633-F7E6-4B46-9DF6-19F91402ADBBQ24804919-BF27A5E1-47FA-46EF-9B54-33E1008A16CDQ27683637-CD0CE7E1-4E43-494B-820D-DE1A7C2DB209Q28204785-8799999C-118D-4151-9EC8-67D73DF26895Q30863574-18BD1C76-FCD2-4E1D-84A2-4447B20B438BQ31938591-E19BA42A-B965-421B-A66E-3EB0B396835CQ33112699-F6FEF953-ECB3-44C7-B10E-6D489A231E1CQ33432974-1AD8547A-15C8-4709-918D-C0077DA13C36Q33493776-CEFDC75B-722C-4F57-88B4-04DF617E1763Q33588113-7EE91BEF-7374-429B-9B01-9086B1BA9E02Q33594076-8BDE65C7-8BC8-4CDE-91AE-1F15E4B4B304Q33728372-56767E8F-DE03-456B-AD12-BCDEC7AB8B64Q33808862-ACDFFB80-ED70-4040-8827-8A8FE44E9628Q33895858-26776137-8339-412F-A5E3-2D2E3A5BDE25Q33946598-56976FD5-10B4-45C7-8898-AA7E2DB9D0B6Q34219323-DE9D14AB-AAC5-4B6D-8149-B75AB84CFA16Q35059164-B9A325D7-039C-4948-8FFB-13F1ED138B7EQ35330343-184A6A82-3045-4CC5-BBC9-2361B3CCB5F5Q35583352-28A93BC4-3648-476F-8199-5F726AE958E1Q35600002-96F06547-A3AB-474F-8822-AF21E07C10CAQ35665670-98EE8857-BBA8-409A-AAFE-16B977BA15F5Q35715964-1B37A537-43E1-4112-BD44-86A739B10EF8Q36169087-03860A46-6D83-42CD-9806-AD4DAE54BAFDQ36187539-0D7F4556-2865-4423-A356-1BDB43875EEFQ36478024-7ABEF1FA-8CFB-4CFE-93A0-55805195003DQ36491988-C5983E44-8A29-4157-8B6B-6563A0D3F302Q36510112-2C555659-2272-4035-A215-391E9BA93074Q36718335-3D622E6C-F0E6-4632-9CD2-3F082F11DD07Q36731844-09924191-0785-4277-9A6A-6A991FF14939Q36770424-203BB8DD-473C-4E1A-AF46-CBC99BCC1134Q36949574-CC78BD22-7B6E-4C0A-9CE2-13286EC89876Q37086180-BB8C5605-03F1-47DF-96D9-CF3AD39F585CQ37118192-9A1AE221-6E4E-448F-A140-84A46B97A340Q37164504-6F0F72A2-934A-4282-9E98-F78A1B8D0516Q37213540-241D61A8-99D7-4326-BD62-BD196CB739E3
P2860
Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma
description
1993 nî lūn-bûn
@nan
1993 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Novel nuclear autoantigen with ...... from hepatocellular carcinoma
@ast
Novel nuclear autoantigen with ...... from hepatocellular carcinoma
@en
Novel nuclear autoantigen with ...... from hepatocellular carcinoma
@en-gb
Novel nuclear autoantigen with ...... from hepatocellular carcinoma
@nl
type
label
Novel nuclear autoantigen with ...... from hepatocellular carcinoma
@ast
Novel nuclear autoantigen with ...... from hepatocellular carcinoma
@en
Novel nuclear autoantigen with ...... from hepatocellular carcinoma
@en-gb
Novel nuclear autoantigen with ...... from hepatocellular carcinoma
@nl
prefLabel
Novel nuclear autoantigen with ...... from hepatocellular carcinoma
@ast
Novel nuclear autoantigen with ...... from hepatocellular carcinoma
@en
Novel nuclear autoantigen with ...... from hepatocellular carcinoma
@en-gb
Novel nuclear autoantigen with ...... from hepatocellular carcinoma
@nl
P2093
P2860
P921
P356
P1476
Novel nuclear autoantigen with ...... from hepatocellular carcinoma
@en
P2093
P2860
P304
P356
10.1172/JCI116848
P407
P50
P577
1993-11-01T00:00:00Z